The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

BACKGROUND: The aim of this study was to evaluate the effect on the number of performed biopsies and costs associated with implementing positron emission tomography (PET) and computed tomography (PET/CT) with 16α-[(18)F]fluoro-17β-oestradiol (FES) or 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) as an upf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Autores principales: Koleva-Kolarova, R G, Greuter, M J W, van Kruchten, M, Vermeulen, K M, Feenstra, T, Buskens, E, Glaudemans, A W J M, de Vries, E F J, de Vries, E G E, Hospers, G A P, de Bock, G H
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430721/
https://ncbi.nlm.nih.gov/pubmed/25880006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.138
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares